GlaxoSmithKline has identified more than 5,500 rare diseases it potentially could target as part of...
With exception to those companies that are the first to win Food and Drug Administration...
The Food and Drug Administration has given E. Fougera & Co. approval for the first...
A Pfizer executive credited with diversifying the company’s portfolio and helping create a joint venture...
Mylan had profits of $93.5 million in 2009, the generic drug maker announced Thursday in...
An investigational drug for treating breast cancer will garner sales of more than $1 billion...
Endo Pharmaceuticals saw profits of $334.3 million in 2009, a 9% increase over 2008’s $305.7...
The Food and Drug Administration has declined to approve the use of a drug made...
The Food and Drug Administration is reviewing data from a large clinical study of a...
President Barack Obama’s proposed healthcare bill may have its supporters and detractors, but one group...
Watson Pharmaceuticals had profits of $348.8 million for 2009, according to annual financial results announced...
The Food and Drug Administration hopes to accelerate the review process for generic drugs, according...
A report released over the weekend by a Senate committee linked a drug used to...
Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for...
British drug maker GlaxoSmithKline issued a response to new labeling requirements proposed by the Food...
Choosing the wrong liquid Maalox product can have harmful consequences, the Food and Drug Administration...
Anglo-Swedish drug maker AstraZeneca and American drug maker Rigel Pharmaceuticals have signed a global licensing...
Merck & Co. has appointed former Johnson & Johnson executive Bridgette Heller to serve as...
Teva Pharmaceutical Industries got a big boost in profits in 2009 compared with 2008, the...
On a lot of issues, the branded and generic drug industries agree about as readily...
Advertisements on television for drugs have become ubiquitous, but some drug makers are looking for...
Some investors quoted in published reports foresee huge gains for such retail pharmacy chains as...
Traditional care delivery models will continue to give way to alternative care delivery models, such...
Pfizer, Merck & Co. and Roche have made big mega-acquisitions. Eli Lilly has pumped money...
Patients with limited insurance coverage will have increased access to cancer and specialty drugs under...